Sarah M. Kehoe

4.0k total citations · 2 hit papers
12 papers, 2.0k citations indexed

About

Sarah M. Kehoe is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Sarah M. Kehoe has authored 12 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Surgery and 4 papers in Oncology. Recurrent topics in Sarah M. Kehoe's work include Melanoma and MAPK Pathways (4 papers), Computational Drug Discovery Methods (2 papers) and Sepsis Diagnosis and Treatment (2 papers). Sarah M. Kehoe is often cited by papers focused on Melanoma and MAPK Pathways (4 papers), Computational Drug Discovery Methods (2 papers) and Sepsis Diagnosis and Treatment (2 papers). Sarah M. Kehoe collaborates with scholars based in United States, Germany and Puerto Rico. Sarah M. Kehoe's co-authors include Laura E. MacConaill, Levi A. Garraway, William C. Hahn, Matthew Meyerson, Michael F. Berger, Cory M. Johannessen, Panisa Pochanard, Matthew J. Davis, Allison M. Sawyer and Nikhil Wagle and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Molecular and Cellular Biology.

In The Last Decade

Sarah M. Kehoe

12 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recurrent BRAF mutations in Langerhans cell histiocytosis

2010 742 citations Gayane Badalian‐Very, Jo‐Anne Vergilio et al. Blood profile →
Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling

2011 732 citations Nikhil Wagle, Michael F. Berger et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarah M. Kehoe United States	9	1.1k	801	641	403	336	12	2.0k
Mithun Vinod Shah United States	18	461 0.4×	336 0.4×	393 0.6×	311 0.8×	78 0.2×	154	1.6k
Fabienne Meggetto France	24	593 0.5×	971 1.2×	248 0.4×	802 2.0×	118 0.4×	60	2.0k
Markus Rechsteiner Switzerland	24	818 0.8×	572 0.7×	106 0.2×	193 0.5×	169 0.5×	66	1.7k
Cliff Meldrum Australia	24	1.0k 1.0×	1.1k 1.3×	70 0.1×	619 1.5×	188 0.6×	57	2.6k
Camilla Pilati France	19	1.1k 1.0×	1.1k 1.3×	161 0.3×	440 1.1×	408 1.2×	32	2.7k
Laura Galluzzo Argentina	13	876 0.8×	425 0.5×	80 0.1×	140 0.3×	154 0.5×	40	1.6k
Magdalena Martinka Canada	26	1.2k 1.1×	728 0.9×	98 0.2×	348 0.9×	84 0.3×	62	2.3k
Jeffrey Lin United States	19	558 0.5×	794 1.0×	117 0.2×	381 0.9×	83 0.2×	39	1.6k
Lisa Simi Italy	27	801 0.7×	706 0.9×	104 0.2×	151 0.4×	207 0.6×	53	1.8k
Ying C. Henderson United States	25	1.3k 1.2×	1.0k 1.3×	74 0.1×	131 0.3×	126 0.4×	39	2.4k

Countries citing papers authored by Sarah M. Kehoe

Since Specialization

Citations

This map shows the geographic impact of Sarah M. Kehoe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah M. Kehoe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah M. Kehoe more than expected).

Fields of papers citing papers by Sarah M. Kehoe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah M. Kehoe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah M. Kehoe. The network helps show where Sarah M. Kehoe may publish in the future.

Co-authorship network of co-authors of Sarah M. Kehoe

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah M. Kehoe. A scholar is included among the top collaborators of Sarah M. Kehoe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah M. Kehoe. Sarah M. Kehoe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Levin, Scott, et al.. (2025). The Complete Blood Count Sepsis Index Using Monocyte Distribution Width for Early Detection of Sepsis in Patients Without Obvious Signs. Critical Care Explorations. 7(1). e1194–e1194. 1 indexed citations

Yonker, Lael M., Oluwakemi Badaki‐Makun, Puneeta Arya, et al.. (2022). Monocyte anisocytosis increases during multisystem inflammatory syndrome in children with cardiovascular complications. BMC Infectious Diseases. 22(1). 563–563. 8 indexed citations

Le, Sidney, Samson Mataraso, Jacob Calvert, et al.. (2019). 24: EFFECTS OF MONOCYTE DISTRIBUTION WIDTH AND WHITE BLOOD CELL COUNT ON A SEPSIS PREDICTION ALGORITHM. Critical Care Medicine. 48(1). 12–12. 1 indexed citations

Wagle, Nikhil, Michael F. Berger, Matthew J. Davis, et al.. (2011). Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling. Journal of Clinical Oncology. 29(22). 3085–3096. 732 indexed citations breakdown →

Wagle, Nikhil, Michael F. Berger, Matthew J. Davis, et al.. (2011). Abstract 3933: Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling. Cancer Research. 71(8_Supplement). 3933–3933. 1 indexed citations

Kießling, Michael K., Patrick A. Oberholzer, Chandrani Mondal, et al.. (2011). High-throughput mutation profiling of CTCL samples reveals KRAS and NRAS mutations sensitizing tumors toward inhibition of the RAS/RAF/MEK signaling cascade. Blood. 117(8). 2433–2440. 60 indexed citations

Deshpande, Vikram, Stephanie M. Zimmerman, Sarah M. Kehoe, et al.. (2011). Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma. BMC Cancer. 11(1). 60–60. 74 indexed citations

Badalian‐Very, Gayane, Jo‐Anne Vergilio, Barbara Degar, et al.. (2010). Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood. 116(11). 1919–1923. 742 indexed citations breakdown →

Miron, Alexander, Mária Váradi, Daniel R. Carrasco, et al.. (2010). PIK3CA Mutations in In situ and Invasive Breast Carcinomas. Cancer Research. 70(14). 5674–5678. 107 indexed citations

10.

Søndergaard, Jonas Nørskov, Ramin Nazarian, Qi Wang, et al.. (2010). Differential sensitivity of melanoma cell lines with BRAF V600E mutation to the specific Raf inhibitor PLX4032. Journal of Translational Medicine. 8(1). 171 indexed citations

11.

Kehoe, Sarah M., Masahiro Oka, Nina Reichert, et al.. (2008). A Conserved E2F6-Binding Element in Murine Meiosis-Specific Gene Promoters1. Biology of Reproduction. 79(5). 921–930. 35 indexed citations

12.

Hamazaki, Takashi, Sarah M. Kehoe, Toru Nakano, & Naohiro Terada. (2006). The Grb2/Mek Pathway Represses Nanog in Murine Embryonic Stem Cells. Molecular and Cellular Biology. 26(20). 7539–7549. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact